CEVI.ST
Price:
$238
Market Cap:
$5.68B
CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; Cel...[Read more]
Industry
Medical - Devices
IPO Date
2007-05-28
Stock Exchange
STO
Ticker
CEVI.ST
According to CellaVision AB (publ)’s latest financial reports and current stock price. The company's current ROE is 20.15%. This represents a change of 297.47% compared to the average of 5.07% of the last 4 quarters.
The mean historical ROE of CellaVision AB (publ) over the last ten years is 24.71%. The current 20.15% ROE has changed -18.46% with respect to the historical average. Over the past ten years (40 quarters), CEVI.ST's ROE was at its highest in in the September 2015 quarter at 14.56%. The ROE was at its lowest in in the September 2022 quarter at 1.71%.
Average
24.71%
Median
25.77%
Minimum
18.19%
Maximum
30.54%
Discovering the peaks and valleys of CellaVision AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 45.57%
Maximum Annual ROE = 30.54%
Minimum Annual Increase = -26.84%
Minimum Annual ROE = 18.19%
Year | ROE | Change |
---|---|---|
2023 | 18.19% | -1.37% |
2022 | 18.44% | -20.06% |
2021 | 23.07% | 10.77% |
2020 | 20.83% | -26.84% |
2019 | 28.47% | -6.80% |
2018 | 30.54% | 5.51% |
2017 | 28.95% | -0.19% |
2016 | 29.00% | 0.77% |
2015 | 28.78% | 38.40% |
2014 | 20.80% | 45.57% |
The current ROE of CellaVision AB (publ) (CEVI.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.90%
5-year avg
21.80%
10-year avg
24.71%
CellaVision AB (publ)’s ROE is greater than Vitrolife AB (publ) (-29.16%), less than Biotage AB (publ) (6.79%), less than Sectra AB (publ) (30.05%), less than BioGaia AB (publ) (18.22%), less than Mycronic AB (publ) (30.58%),
Company | ROE | Market cap |
---|---|---|
-29.16% | $32.77B | |
6.79% | $12.74B | |
30.05% | $54.98B | |
18.22% | $10.57B | |
30.58% | $39.33B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CellaVision AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CellaVision AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CellaVision AB (publ)'s ROE?
How is the ROE calculated for CellaVision AB (publ) (CEVI.ST)?
What is the highest ROE for CellaVision AB (publ) (CEVI.ST)?
What is the 3-year average ROE for CellaVision AB (publ) (CEVI.ST)?
What is the 5-year average ROE for CellaVision AB (publ) (CEVI.ST)?
How does the current ROE for CellaVision AB (publ) (CEVI.ST) compare to its historical average?